By The Associated Press
THE NEWS: Arena Pharmaceutical's anti-obesity drug Belviq received regulatory approval Wednesday, the first such drug to get FDA clearance for long-term weight loss in 13 years.
THE DRUG: Belviq is approved for adults who are obese or are overweight with at least one medical complication, such as diabetes or high cholesterol. It should be used in combination with a healthy diet and exercise.
THE RESULTS: On average patients lost 3 to 3.7 percent of their starting body weight over a year. About 47 percent of patients without diabetes lost at least 5 percent of their weight or more.
Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.